Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000053417-13-000141
Filing Date
2013-02-13
Accepted
2013-02-13 15:41:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 13G/A ANNUAL FILING - VRTX vrtx1212.txt SC 13G/A 7148
  Complete submission text file 0000053417-13-000141.txt   8693
Mailing Address 466 LEXINGTON AVE NEW YORK NY 10017
Business Address 466 LEXINGTON AVE NEW YORK NY 10017 2124211000
JENNISON ASSOCIATES LLC (Filed by) CIK: 0000053417 (see all company filings)

EIN.: 132631108 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6173416100
VERTEX PHARMACEUTICALS INC / MA (Subject) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-42126 | Film No.: 13602789
SIC: 2834 Pharmaceutical Preparations